1. Most Discussed
  2. Gainers & Losers
PSD 0.0¢

uk listing here we come

  1. AimForSimon

    7,078 Posts.
    ASX RELEASE 9 September 2003
    UK broker appointed to list pSiMedica
    Australian nanotechnology company pSivida Limited (ASX: PSD) is pleased to announce Evolution Beeson Gregory Ltd (“EVBGL”) has been appointed to assist with the listing of its UK operating subsidiary, pSiMedica on the London Stock Exchange (“LSE”).
    EVBGL has been mandated to assist pSiMedica with its upcoming listing on either the main board of the LSE or the Alternative Investment Market (“AIM”). It is anticipated that the listing will occur no later than September 2004.
    Importantly the listing will provide pSiMedica with access to significant overseas capital markets, increased support from European Institutions and further coverage and support of the BioSiliconTM technology.
    Mr Nick Rodgers, Director of EVBGL, said “pSiMedica has developed some very interesting technology which has very exciting prospects in a number of therapeutic and other applications and we are pleased to be associated with the Company.”
    pSivida Managing Director Mr Gavin Rezos said, “We are pleased to have the assistance of EVBGL in listing pSiMedica. EVBGL are a well respected investment house and have a strong association with nanotechnology. They have significant experience and expertise in listing companies in the UK with a well established institutional network. We look forward to working with them closely in what is a significant milestone for the company.”
    EVBGL is the investment banking business of UK listed Evolution Group plc providing equity research, institutional sales & trading and corporate finance advice.
    At the time of listing it is expected that pSivida will have its own BioSiliconTM product lines, such that pSivida shareholders will retain an interest in pSivida as well as an intention for them to receive pSiMedica script. Details of the listing and how pSivida shareholders may be able to participate directly in the offering will be provided closer to the listing date.
    Released by:
    Josh Mann
    Investor Relations
    pSivida Limited
    Tel: + 61 8 9226 5099
    [email protected]

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.